Your session is about to expire
← Back to Search
Patient Advocacy + Home Visits for Asthma (HAP3 Trial)
HAP3 Trial Summary
This trial is exploring whether two interventions, a patient advocate and home visits, can improve asthma outcomes in low-income minority patients.
HAP3 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowHAP3 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HAP3 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with asthma by a doctor.I am over 18 and live in a low-income area of Philadelphia.I do not have chronic lung diseases like cystic fibrosis or pulmonary hypertension.I have asthma and may also have COPD, especially if I smoke.I needed prednisone or had to visit the ED or was hospitalized for asthma in the last year.I am using an inhaled corticosteroid for my asthma.I have smoked 20 or fewer pack-years of cigarettes.
- Group 1: Clinical intervention
- Group 2: Clinical intervention AND Home Visit AND Feedback
- Group 3: Clinical intervention AND Feedback
- Group 4: Clinical intervention AND Home Visit
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this medical experiment actively seeking participants?
"Reported on clinicaltrials.gov, this medical investigation has been actively recruiting since August 21st 2019 and was last modified on 26th of August 2022."
How many participants are currently signed up for this research initiative?
"Affirmative. The clinicaltrials.gov website suggests that this trial is actively enlisting participants since it was first posted on August 21st 2019, with the most recent changes being made to the page on August 26th 2022. 400 patients need to be recruited from two medical centres."
What are the expected outcomes of this research endeavor?
"The primary assessment of this clinical trial is Asthma Control measured over the course of 15 months. Secondary outcomes include: Emergency Department (ED) visits for asthma documented in electronic medical records and patient reports, an asthma-related quality of life score derived from a 15-item survey with higher scores indicating better health, as well as Forced Expiratory Volume in 1 second (FEV1)."
Share this study with friends
Copy Link
Messenger